CompoAtlas

TYP Selenium Tablet

Natural health product licensed in Canada

Other names
Bestwell Selenium Tablet
Licence holder
TYP Pharmaceutical Ltd.
NPN or DIN-HM
80071301
Status
Active licence
Licence date
21 July 2016
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sélénium

Source : Enriched yeast

200 microgrammesNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Cellulose, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé1 Tous les jours

Uses authorised in Canada

Source of an antioxidant that helps protect cell against the oxidative damage caused by free radicals. Helps to maintain the normal function of thyroid gland.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80071301

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line